Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-28

FDA Approved: FOSPHENYTOIN — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for fosphenytoin sodium (Fosphenytoin) from Fresenius Kabi USA, LLC. The action confirms an approved supplement (AP) for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • fosphenytoin (fosphenytoin)

Snippet

SUPPL AP for FOSPHENYTOIN (FOSPHENYTOIN SODIUM)